In this free webinar, learn about advancements in cell line development and glycoengineering. Attendees will gain insights into how precise glycan modulation boosts antibody-dependent cell-mediated ...

The medication triggers the death of the inflammation-driving B-cells via two main mechanisms: antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).

People with vasculitis may need at least three or four vaccinations for COVID-19 before they start to show an immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...

antibody-dependent cellular phagocytosis (ADCP), antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent complement deposition (ADCD), and CDC. All three anti-CD20 mAbs, RTX ...

When antibodies like Briumvi bind to target proteins on cells, they can kill the cell through two main mechanisms: antibody-dependent cellular cytotoxicity, known as ADCC, or complement-dependent ...

Share on Pinterest Scientists have found that an antibody treatment prevented a decline in muscle mass and bone density after using GLP-1 drugs. Rob and Julia Campbell/Stocksy Aging and limited ...

and on the other side binds to NK cells to stimulate a phenomenon known as antibody-dependent cellular cytotoxicity (ADCC), which prompts immune cells to kill cancer cells. Experiments on NSCLC ...

Scholar Rock has submitted its anti-myostatin antibody apitegromab for FDA approval, just months after reporting that it hit its primary endpoint in phase III for spinal muscular atrophy (SMA).

The company’s pipeline includes four bispecific antibody candidates, with two programmes – BBT001 and BBT002 – set to enter the clinic later on in 2025. BBT001 is being investigated for dermatologic ...

and on the other side binds to NK cells to stimulate a phenomenon known as antibody-dependent cellular cytotoxicity (ADCC), which prompts immune cells to kill cancer cells. Experiments on NSCLC ...

ADCC: Antibody-dependent cellular cytotoxicity; CDC: Complement-dependent cytotoxicity. Ofatumumab shows good efficacy in conditions with low CD20 expression and is approved for relapsed ...